Characterization of in vitro immunoselected variants from a highly metastatic murine tumor for alterations in malignant behavior in vivo.
Characterization of in vitro immunoselected variants from a highly metastatic murine tumor for alterations in malignant behavior in vivo.
复制标题
来自高度转移性小鼠肿瘤的体外免疫选择变体的表征,用于改变体内恶性行为。
DOI:
10.1002/ijc.2910330518
复制
发表时间:
1984
影响因子:
6.4
通讯作者:
Kerbel,RS
中科院分区:
文献类型:
--
作者:
Liteplo,RG;Frost,P;Donaghue,TP;Kerbel,RS
A new Ly‐6.2−antigen‐loss variant (called L61‐MI) of the highly metastatic DBA/2 mouse (Ly‐6.2+) MDAY‐D2 tumor has been obtained by means of a monoclonal anti‐Ly‐6.2 antibody in anin vitroimmunoselection technique. Whereas L61‐MI grew poorly when inoculated subcutaneously into the syngeneic host, it grew and metastasized in a similar way to the parental MDAY‐D2 tumor when inoculated into immunosuppressed, athymic nude mice. L61‐MI as well as another Ly‐6.2−variant of the same MDAY‐D2 tumor (called L61) which is poorly metastatic in the syngeneic host salvaged exogenous fucose into glycoproteins and glycolipids at rates 5.5 and 7.8 times that of the parental MDAY‐D2 line. In contrast, the Ly‐6.2−variants exhibited a 50–70% decrease in the incorporation of exogenous mannose into glycoproteins and glycolipids. L61‐MI and L61 also exhibited alterations in the structures of the oligosaccharide moieties linked to the cell surface glycoproteins and/or glycolipids. Thus, thein vitroimmunoselection technique can be used to obtain a panel of variants with stable phenotypic alterations in their growth and metastatic capacities. Such mutants may, like previously described lectin‐resistant mutants, be useful in studying the contribution of cell surface glycoproteins and glycolipids to tumorigenicity and metastasis.